EventsViruses 2026 – New Horizons in Virology
Published
This submission belongs to the session S5. Virus-Host Interactions of the event Viruses 2026 – New Horizons in Virology
Published date
09 Mar, 2026
Academic Editor
author-avatarEric Freed
Citation
Stephanie Pfänder, Dissecting Emerging Viruses at the Host Interface, in Proceedings of Viruses 2026 – New Horizons in Virology, Barcelona, 11 March–13 March 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Dissecting Emerging Viruses at the Host Interface

1. Research Unit Emerging Viruses, Leibniz Institute of Virology, Hamburg, Germany, Germany
Abstract

Flaviviruses and coronaviruses have repeatedly emerged as major human pathogens, causing outbreaks with significant public health, economic, and societal impacts. Their continued emergence and re-emergence underscore the urgent need to better understand the host-specific determinants that shape susceptibility to infection and disease severity. Our research focuses on dissecting virus–host interactions that govern viral replication and immune control, with particular emphasis on interferon-mediated innate immune responses. We investigate how differences in interferon signaling pathways influence cellular permissiveness to infection and determine the efficiency of viral replication and spread. In parallel, we study host dependency factors that are exploited by flaviviruses and coronaviruses throughout their replication cycles, from viral entry and genome replication to assembly and egress. Identifying these essential host factors provides critical insight into conserved mechanisms of viral replication and reveals potential targets for host-directed antiviral strategies. Together, these interdisciplinary efforts aim to define key determinants of viral emergence and pathogenesis, improve our ability to predict infection outcomes, and inform the development of effective antiviral interventions that are robust to viral evolution.

Keywords
coronaviruses
flaviviruses
Intracellular antibody immunity and the targeted degradation of pathogens
Dissecting the host-virus interface for broad-spectrum antiviral therapy